US 7314631
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
granted A61KA61K2039/5254A61K2039/5256
Quick answer
US patent 7314631 (Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K2039/5254, A61K2039/5256, A61K2039/70, A61K39/12